(0.01%) 5 207.00 points
(0.08%) 39 028 points
(-0.08%) 18 181 points
(-0.05%) $78.44
(-1.55%) $2.16
(-0.18%) $2 326.90
(-0.64%) $27.44
(0.19%) $966.70
(0.10%) $0.929
(0.32%) $10.86
(0.22%) $0.798
(-0.57%) $90.82
4.35% € 0.360
Live Chart Being Loaded With Signals
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide...
Stats | |
---|---|
Volumen de hoy | 5 275.00 |
Volumen promedio | 12 639.00 |
Capitalización de mercado | 2.71M |
EPS | €0 ( 2024-04-21 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.129 |
ATR14 | €0.380 (105.56%) |
Volumen Correlación
Paion AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Paion AG Correlación - Moneda/Commodity
Paion AG Finanzas
Annual | 2022 |
Ingresos: | €33.25M |
Beneficio Bruto: | €31.29M (94.10 %) |
EPS: | €-0.0812 |
FY | 2022 |
Ingresos: | €33.25M |
Beneficio Bruto: | €31.29M (94.10 %) |
EPS: | €-0.0812 |
FY | 2021 |
Ingresos: | €7.13M |
Beneficio Bruto: | €4.05M (56.83 %) |
EPS: | €-0.310 |
FY | 2020 |
Ingresos: | €19.66M |
Beneficio Bruto: | €19.66M (100.00 %) |
EPS: | €0.0295 |
Financial Reports:
No articles found.
Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico